No Data
Returns On Capital At Sirio Pharma (SZSE:300791) Have Hit The Brakes
sirio pharma (300791.SZ) plans to invest no more than $40 million to build a production base in Thailand to avoid global supply chain risks.
Sirio Pharma (300791.SZ) announced that, in order to meet the needs of the company's global business development, it will improve the global supply chain...
Xianle Health: Report for the third quarter of 2024
Sirio Pharma (300791.SZ): Net income in the third quarter was 85.3283 million yuan, a year-on-year increase of 1.63%.
Galaxy News October 23rd | Sirio Pharma (300791.SZ) released its third quarter report for 2024, with quarterly revenue of 1.058 billion yuan, a year-on-year increase of 10.43%; net income attributable to the shareholders of the listed company was 85.3283 million yuan, a year-on-year increase of 1.63%; net income attributable to the shareholders of the listed company after deducting non-recurring gains and losses was 81.8877 million yuan, a year-on-year decrease of 4.62%; basic earnings per share of 0.47 yuan.
Sirio Pharma (300791.SZ) released its performance for the first three quarters, with a net income of 0.24 billion yuan, a year-on-year increase of 29.52%.
Sirio Pharma (300791.SZ) released the third quarter report for 2024, with revenue for the first three quarters reaching 30...
Sirio Pharma (SZSE:300791) Seems To Use Debt Quite Sensibly
Take Care Before Diving Into The Deep End On Sirio Pharma Co., Ltd. (SZSE:300791)
